Characteristics | No. of patients | OR (95% CI) | P for interaction |
---|---|---|---|
Age | Â | Â | 0.6675 |
 60–73 | 472 | 1.45 (1.02, 2.05) |  |
 74–81 | 457 | 1.18 (0.86, 1.61) |  |
 82–108 | 515 | 1.23 (1.04, 1.46) |  |
Sex | Â | Â | 0.7661 |
 Male | 389 | 1.28 (1.02, 1.60) |  |
 Female | 1055 | 1.33 (1.13, 1.57) |  |
Comorbidity | 1042 | 1.29 (1.12, 1.50) | 0.8063 |
Coronary heart disease | 190 | 1.41 (1.07, 1.85) | 0.5415 |
Stroke | 257 | 1.52 (1.17, 1.97) | 0.2313 |
Parkinson’s disease | 33 | 1.14 (0.31, 4.20) | 0.8137 |
WBC count | Â | Â | 0.1311 |
 ≤ 7.99 | 464 | 1.42 (1.12, 1.81) |  |
 8.00–9.99 | 394 | 1.54 (1.20, 1.97) |  |
 ≥ 10.00 | 586 | 1.12 (0.90, 1.40) |  |
MLR | Â | Â | 0.0967 |
 ≤ 0.366 | 480 | 1.59 (1.29, 1.97) |  |
 0.367–0.566 | 482 | 1.17 (0.88, 1.55) |  |
 ≥ 0.567 | 482 | 1.18 (0.94, 1.48) |  |
NLR | Â | Â | 0.7724 |
 ≤ 4.32 | 481 | 1.43 (1.10, 1.87) |  |
 4.33–6.99 | 480 | 1.29 (1.02, 1.64) |  |
 ≥ 7.00 | 483 | 1.27 (1.04, 1.55) |  |
Hemoglobin | Â | Â | 0.1695 |
 ≤ 108 | 464 | 1.28 (1.07, 1.53) |  |
 108–124 | 473 | 1.01 (0.71, 1.43) |  |
 ≥ 125 | 507 | 1.59 (1.15, 2.20) |  |
Albumin | Â | Â | 0.4294 |
 ≤ 37.0 | 441 | 1.25 (1.03, 1.52) |  |
 37.1–39.4 | 515 | 1.14 (0.84, 1.56) |  |
 ≥ 39.5 | 488 | 1.47 (1.14, 1.89) |  |
AGR | Â | Â | 0.6146 |
 ≤ 1.29 | 481 | 1.24 (1.05, 1.47) |  |
 1.30–1.42 | 481 | 1.42 (1.07, 1.90) |  |
 ≥ 1.43 | 482 | 1.14 (0.79, 1.66) |  |
Serum creatinine | Â | Â | 0.9036 |
 ≤ 56.9 | 480 | 1.28 (0.97, 1.68) |  |
 57–73.8 | 480 | 1.27 (0.99, 1.62) |  |
 ≥ 73.9 | 484 | 1.35 (1.10, 1.66) |  |
Blood urea nitrogen | Â | Â | 0.2690 |
 ≤ 3.81 | 475 | 1.09 (0.81, 1.48) |  |
 3.82–6.19 | 481 | 1.50 (1.17, 1.93) |  |
 ≥ 6.20 | 488 | 1.31 (1.07, 1.60) |  |
ASA classification | Â | Â | 0.3382 |
 ≤ 2 | 624 | 1.43 (1.12, 1.84) |  |
 ≥ 3 | 820 | 1.24 (1.05, 1.45) |  |
Intraoperative blood loss | Â | Â | 0.4680 |
 ≤ 149 | 471 | 1.19 (0.95, 1.48) |  |
 150–299 | 420 | 1.43 (1.15, 1.79) |  |
 ≥ 300 | 553 | 1.37 (1.04, 1.81) |  |
ICU admission | 31 | 1.58 (0.93, 2.66) | 0.3819 |